drugset / Trial / NCT02773485

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

NCT02773485 ↗

Phase 3 Unknown 155 enrolled Tata Memorial Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The study evaluates impact of high dose radiation on overall survival in patients with unresectable nonmetastatic cholangiocarcinoma. The study randomizes patient between systemic chemotherapy alone and systemic chemotherapy and high dose radiation

Timeline

Start
2015-05
Primary completion
2025-06
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 25 mg/m2 —
Background Gemcitabine Small molecule 1000 mg/m2 —

Indications